LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
Clinical trial NCT02649673 · TERMINATED
Trial details
- NCT number
- NCT02649673
- Sponsor
- SCRI Development Innovations, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-23
- Primary completion
- 2021-07-30
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.